Year: 2025
Type: article
Abstract: Dupilumab-associated head and neck dermatitis (HND) is a rare and often underrecognized condition, especially in patients with skin of color. It can vary from subtle to severe presentations, with violaceous hues and seborrheic distribution after dupilumab initiation. Early recognition and management are crucial to prevent treatment discontinuation.
Source: Clinical Case Reports
DOI: 10.1002/ccr3.70271
Authors: Divya M. Shan, Marisa Riley, David M. Milgraum
Institution: Virginia Commonwealth University
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,820
OpenAlex ID: W4408070312
